1. Considered and approved Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2025 along with the Limited review report; 2. Other routine businesses with the permission of chair

pdf

Choksi Laboratories Ltd.

06 Nov 2025, 12:34PM

121.55

-1.18%

Board Meeting

Choksi Laboratories Ltd - 526546 - Board Meeting Intimation for Board Meeting To Be Held On …

BSE India

Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter and Half year ended on 30th September, 2025; 2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting, which shall include at least one independent Director. If any.

pdf

Choksi Laboratories Ltd.

11 Oct 2025

121.55

-1.18%

Company Update

Choksi Laboratories Ltd - 526546 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certification for compliance under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30.09.2025

pdf

Choksi Laboratories Ltd.

26 Sep 2025

121.55

-1.18%

SAST

Choksi Laboratories Ltd - 526546 - Closure of Trading Window

BSE India

Intimation for closure of trading window w.e.f. 01st October, 2025

pdf

Choksi Laboratories Ltd.

17 Sep 2025

121.55

-1.18%

AGM

Choksi Laboratories Ltd - 526546 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

The Voting result and Scrutinizer Report for the remote and e-voting facility during the 32nd Annual General Meeting of the company held on 16.09.2025

pdf